4548 Stock Overview
Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Seikagaku Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥804.00 |
| 52 Week High | JP¥914.00 |
| 52 Week Low | JP¥730.00 |
| Beta | 0.21 |
| 1 Month Change | 0.88% |
| 3 Month Change | -7.37% |
| 1 Year Change | 5.65% |
| 3 Year Change | -14.56% |
| 5 Year Change | -33.77% |
| Change since IPO | -62.79% |
Recent News & Updates
Shareholder Returns
| 4548 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 2.8% | 0.9% | 2.1% |
| 1Y | 5.7% | 11.8% | 15.6% |
Return vs Industry: 4548 underperformed the JP Pharmaceuticals industry which returned 12.8% over the past year.
Return vs Market: 4548 underperformed the JP Market which returned 16.3% over the past year.
Price Volatility
| 4548 volatility | |
|---|---|
| 4548 Average Weekly Movement | 2.3% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in JP Market | 7.2% |
| 10% least volatile stocks in JP Market | 1.8% |
Stable Share Price: 4548 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4548's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | 988 | Ken Mizutani | www.seikagaku.co.jp |
Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally The company operates in two segments, Pharmaceuticals and LAL Business. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and HERNICORE for the treatment of lumbar disc herniation.
Seikagaku Corporation Fundamentals Summary
| 4548 fundamental statistics | |
|---|---|
| Market cap | JP¥43.88b |
| Earnings (TTM) | JP¥2.02b |
| Revenue (TTM) | JP¥38.36b |
21.8x
P/E Ratio1.1x
P/S RatioIs 4548 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4548 income statement (TTM) | |
|---|---|
| Revenue | JP¥38.36b |
| Cost of Revenue | JP¥19.96b |
| Gross Profit | JP¥18.41b |
| Other Expenses | JP¥16.39b |
| Earnings | JP¥2.02b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 07, 2025
| Earnings per share (EPS) | 36.92 |
| Gross Margin | 47.98% |
| Net Profit Margin | 5.25% |
| Debt/Equity Ratio | 0.4% |
How did 4548 perform over the long term?
See historical performance and comparisonDividends
3.7%
Current Dividend Yield76%
Payout RatioDoes 4548 pay a reliable dividends?
See 4548 dividend history and benchmarks| Seikagaku dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 24 2025 |
| Days until Ex dividend | 87 days |
| Days until Dividend pay date | 175 days |
Does 4548 pay a reliable dividends?
See 4548 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 01:07 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Seikagaku Corporation is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Akitada Iwasa | Daiwa Securities Co. Ltd. |
| Masao Yoshida | Ichiyoshi Research Institute Inc. |
| Ippei Koga | Marusan Securities Co. Ltd. |